The current pharma business model is unsustainable
World of DTC Marketing
SEPTEMBER 7, 2022
Although COVID-19 has slowed the growth of drug sales, the oncology market’s total growth is driven by the targeted drugs in oncology. While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. ASH Clinical News takes it a step further.
Let's personalize your content